IP Library Granted Patent US 7,973,081
Granted Patent B2
US 7,973,081 · App. 11/829,428 · Granted Jul 5, 2011

Emulsion compositions containing quaternary ammonium compounds

Assignee: Novagali Pharma SA
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,973,081
App. No.
11/829,428
Granted
Jul 5, 2011
Kind
B2
Abstract

Composition containing quaternary ammonium compounds in which the nitrogen atom is substituted by at least one alkyl group having at least 12 carbon atoms, the composition including at least 20% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 14 carbon atoms and more than 5%, preferably more than 7% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 16 carbon atoms. Ophthalmic oil-in-water emulsions containing such compositions, the ophthalmic emulsions being useful for eye care or for the treatment of eye conditions are also disclosed.

Claims (15)

1. An oil-in-water emulsion comprising:

2% w/w of medium chain triglycerides;

0.005% w/w of cetalkonium chloride;

0.3% w/w of tyloxapol;

0.1% w/w of poloxamer 188;

2.25% w/w of glycerol; and

cyclosporine.

2. The oil-in-water emulsion according to claim 1 , further comprising buffering agents and/or at least one tonicity agent.

3. The oil-in-water emulsion according to claim 2 , wherein the tonicity agent is mannitol.

4. The oil-in-water emulsion according to claim 1 , said emulsion having a positive zeta potential.

5. The oil-in-water emulsion according to claim 1 , said emulsion having a droplet size of 100 to 500 nm.

6. The oil-in-water emulsion according to claim 1 , said emulsion being hypotonic, relative to normal tears.

7. The oil-in-water emulsion according to claim 1 , wherein said emulsion is in the form of a gel suitable for ophthalmic use.

8. A medicament comprising the oil-in-water emulsion according to claim 1 .

9. A method of preparing an ophthalmic composition for dry eye treatment, comprising preparing the emulsion according to claim 1 in a gel form.

Assignments (3)
CHANGE OF ADDRESS Recorded Feb 20, 2025
From: SANTEN
To: SANTEN
Reel/Frame 070276/0582 →
CHANGE OF NAME Recorded Feb 25, 2014
From: NOVAGALI PHARMA SA
To: SANTEN SAS
Reel/Frame 032332/0471 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2007
From: RABINOVICH-GUILATT, LAURA; LAMBERT, GREGORY; LALLEMAND, FREDERIC; PHILIPS, BETTY
To: NOVAGALI PHARMA SA
Reel/Frame 019940/0361 →
Priority Claims (3)
EP 06291236 · Jul 28, 2006 · regional
EP 07112097 · Jul 9, 2007 · regional
WO PCT/IB2007/053441 · Jul 10, 2007 · international
Continuity (2)
Continuation In Part 11494493 · Jul 28, 2006
Related Publication 20080026991A1 · Jan 31, 2008